We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/AI

AI

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Harnessing AI in Clinical Documentation: Evaluating Large Language Model-Generated Hospital Discharge Summaries
AIclinical documentationlarge language models

Harnessing AI in Clinical Documentation: Evaluating Large Language Model-Generated Hospital Discharge Summaries

By MedXY|Oct 6, 2025

A study comparing large language model-generated versus physician-generated discharge summaries found comparable quality and safety, suggesting AI-assisted documentation could reduce clinical burden without compromising patient care.

Personalized Gait Retraining: A Promising Conservative Approach to Medial Knee Osteoarthritis
AIknee osteoarthritis

Personalized Gait Retraining: A Promising Conservative Approach to Medial Knee Osteoarthritis

By MedXY|Oct 6, 2025

A randomized trial shows that personalized foot progression angle modifications significantly reduce medial knee pain and slow cartilage degeneration in medial compartment knee osteoarthritis.

Evaluating the Role of AI Tools in Pharmacy Students’ OSCE Performance and Anxiety: Insights from a Randomized Controlled Trial
AIartificial intelligence

Evaluating the Role of AI Tools in Pharmacy Students’ OSCE Performance and Anxiety: Insights from a Randomized Controlled Trial

By MedXY|Oct 5, 2025

A randomized trial assessing AI-generated study materials revealed no significant impact on pharmacy students’ objective structured clinical examination scores or test anxiety levels, highlighting the need for further research on long-term

Enhancing Depression Care in College Students: AI Chatbots with Social Cues Show Superior Effectiveness
AIAI chatbotdepression

Enhancing Depression Care in College Students: AI Chatbots with Social Cues Show Superior Effectiveness

By MedXY|Oct 5, 2025

A 16-week randomized trial demonstrates that AI chatbots with high-social-cue design significantly reduce depression and anxiety symptoms in college students compared to text-only chatbots, improving adherence, satisfaction, and therapeutic

AI Versus Family Physicians: Evaluating ChatGPT-4o’s Responses to Common Primary Care Queries
AIartificial intelligenceChatGPT-4o

AI Versus Family Physicians: Evaluating ChatGPT-4o’s Responses to Common Primary Care Queries

By MedXY|Oct 5, 2025

This study compares ChatGPT-4o and family physicians in answering 200 common primary care questions, revealing AI’s superior performance in appropriateness, accuracy, comprehensiveness, and empathy, highlighting its potential in enhancing p

Evaluating a Proactive E-Health Intervention for Co-occurring At-Risk Alcohol Use and Depressive Symptoms: Adherence, Reach, and Two-Year Outcomes
AIdepressive symptomse-health intervention

Evaluating a Proactive E-Health Intervention for Co-occurring At-Risk Alcohol Use and Depressive Symptoms: Adherence, Reach, and Two-Year Outcomes

By MedXY|Oct 4, 2025

This RCT assessed a proactive e-health intervention for patients with at-risk alcohol use and depressive symptoms, showing high adherence but only small, non-significant improvements at 12 months and no lasting effects at 24 months.

Harnessing Mobile Health to Improve ADHD Symptoms and Executive Functions in Children: A Randomized Controlled Trial of Tailored Exercise Rehabilitation
AIADHDexercise rehabilitation

Harnessing Mobile Health to Improve ADHD Symptoms and Executive Functions in Children: A Randomized Controlled Trial of Tailored Exercise Rehabilitation

By MedXY|Oct 4, 2025

A tailored, app-supported exercise program delivered via mobile health significantly improves core ADHD symptoms and executive functions in children, demonstrating comparable effectiveness to traditional face-to-face exercise guidance.

Self-Monitoring of Blood Pressure With Mobile App Feedback Enhances Control and Adherence in Uncontrolled Hypertension: Insights From the SMART-BP Trial and Broader Evidence
AIHypertensionmobile health

Self-Monitoring of Blood Pressure With Mobile App Feedback Enhances Control and Adherence in Uncontrolled Hypertension: Insights From the SMART-BP Trial and Broader Evidence

By MedXY|Oct 4, 2025

The SMART-BP trial demonstrates that a mobile app providing tailored feedback significantly improves systolic blood pressure reduction and drug adherence compared to self-monitoring alone, highlighting innovative digital solutions in hypert

Challenges in Distinguishing Human-Authored from AI-Generated Medical Manuscripts and Personal Statements
AIartificial intelligence

Challenges in Distinguishing Human-Authored from AI-Generated Medical Manuscripts and Personal Statements

By MedXY|Oct 4, 2025

Recent studies reveal that human reviewers struggle to differentiate AI-generated medical documents from human-authored texts, with AI often producing higher-quality personal statements that influence evaluation outcomes.

Evaluating Digital Therapeutics for Midlife Women’s Menopausal Symptoms: A Synthesis of Recent Randomized Controlled Trials
AIdigital therapeuticsMenopause

Evaluating Digital Therapeutics for Midlife Women’s Menopausal Symptoms: A Synthesis of Recent Randomized Controlled Trials

By MedXY|Oct 4, 2025

This review synthesizes evidence on mobile digital therapeutics targeting vasomotor and behavioral health symptoms in menopausal and midlife women, highlighting efficacy, engagement, and implications for scalable symptom management.

Efficacy and Safety of ALM-003 Digital Therapeutic in Alcohol Dependence: A Multicenter Open-Label Randomized Controlled Trial
AIbehavioral interventiondigital therapeutics

Efficacy and Safety of ALM-003 Digital Therapeutic in Alcohol Dependence: A Multicenter Open-Label Randomized Controlled Trial

By MedXY|Oct 4, 2025

This review synthesizes evidence from a multicenter RCT showing ALM-003 digital therapeutic reduces heavy drinking days significantly in alcohol-dependent individuals at high risk, with an excellent safety profile.

Harnessing Digital Therapeutics to Improve Glycemic Control in Type 2 Diabetes: Insights from the BRIGHT Trial
AIBehavioral therapydigital therapeutic

Harnessing Digital Therapeutics to Improve Glycemic Control in Type 2 Diabetes: Insights from the BRIGHT Trial

By MedXY|Oct 4, 2025

The BRIGHT trial evaluates AspyreRx, a digital cognitive behavioral therapy, for enhancing glycemic control in type 2 diabetes patients with residual hyperglycemia on stable medical therapy, focusing on efficacy, safety, and real-world appl

Digital Therapeutics in Suicide Prevention: Evidence and Clinical Implications of a Smartphone-Based CBT Intervention
AICognitive Behavioral Therapydigital therapeutics

Digital Therapeutics in Suicide Prevention: Evidence and Clinical Implications of a Smartphone-Based CBT Intervention

By MedXY|Oct 4, 2025

Smartphone-delivered cognitive-behavioral therapy (CBT) via a digital therapeutic app significantly reduces recurrent suicide attempts and sustains reduction in suicidal ideation among adults with prior suicide attempts.

Harnessing Digital Health Technologies in Obesity Management: Insights from a Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Trials
AIobesity managementrandomized controlled trials

Harnessing Digital Health Technologies in Obesity Management: Insights from a Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Trials

By MedXY|Oct 3, 2025

Digital health interventions show modest but clinically meaningful reductions in waist circumference for overweight and obese adults, highlighting their potential as adjuncts in obesity care despite limited effects on weight and behavior.

Advancing Breast Cancer Detection: AI Identifies Missed Interval Cancers on Mammograms
AIartificial intelligencebreast cancer

Advancing Breast Cancer Detection: AI Identifies Missed Interval Cancers on Mammograms

By MedXY|Oct 3, 2025

A recent study shows that an AI system can detect interval breast cancers missed by radiologists on mammograms, potentially improving early diagnosis and screening outcomes in women with dense breasts.

AI-Driven Quantitative CT Reveals Higher Relative Cardiovascular Risk from Coronary Plaque in Women: Insights from the CONFIRM2 Registry
AIcardiovascular riskSex Differences

AI-Driven Quantitative CT Reveals Higher Relative Cardiovascular Risk from Coronary Plaque in Women: Insights from the CONFIRM2 Registry

By MedXY|Oct 3, 2025

AI-based quantitative CT analysis demonstrates that coronary plaque features, while more prevalent in men, confer a disproportionately higher relative risk of major adverse cardiovascular events in women, highlighting the need for sex-speci

Evaluating Electronic Nudges to Enhance Guideline-Directed Therapy in Chronic Kidney Disease: Insights from the NUDGE-CKD Trial
AIchronic kidney diseaseguideline-directed medical therapy

Evaluating Electronic Nudges to Enhance Guideline-Directed Therapy in Chronic Kidney Disease: Insights from the NUDGE-CKD Trial

By MedXY|Oct 3, 2025

The NUDGE-CKD trial found that electronic letter-based nudges to patients with chronic kidney disease and their general practitioners did not significantly improve initiation of guideline-recommended medications over usual care.

Advancing Acute Coronary Syndrome Care: ECG-Based Machine Learning Enhances Risk Stratification
AIacute coronary syndromeelectrocardiogram

Advancing Acute Coronary Syndrome Care: ECG-Based Machine Learning Enhances Risk Stratification

By MedXY|Oct 3, 2025

A prospective study shows that machine learning models trained on 12-lead ECG features outperform HEART score in predicting mortality among chest pain patients, improving risk-based care precision.

The AI Doctor Is Out? How California’s Ab 489 Could Limit AI Development in Healthcare
AIAIhealthcare

The AI Doctor Is Out? How California’s Ab 489 Could Limit AI Development in Healthcare

By MedXY|Oct 3, 2025

California’s AB 489 may reshape AI in healthcare, emphasizing authorized interactions and compliance for AI developers.

Oracle Health Launches AI-First, Voice-Enabled EHR to Enhance Clinician Experience and Compete with Epic
AIartificial intelligenceEHR

Oracle Health Launches AI-First, Voice-Enabled EHR to Enhance Clinician Experience and Compete with Epic

By MedXY|Oct 3, 2025

Oracle Health unveils a next-generation AI-powered, voice-first electronic health record (EHR) system designed from the ground up to improve clinical workflow and challenge Epic’s market dominance in the U.S. acute care sector.

Prev
7 / 9
1…56789
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles